Lidocaine with 0.5 mM concentration could decrease the expression of EGFR by upregulating the level of colorectal cancer cells and miR-520a-3p (retinoblastoma cell line) and inhibit the proliferation of tumor cells (101, 102). Here, EGFR is linked to neoplasm.